It is well understood scientifically that primitive human DNA fragments when injected into a person could 1) activate the immune system and potentially trigger and autoimmune reaction in genetically susceptible people and 2) insert into the genome of blood forming stem cells causing mutations. As the DNA in the genes govern the function of the cells, such DNA insertions can seriously disrupt the function of the mutated cell. Sound Choice Pharmaceutical Institute (SCPI) researches the potential health risks of the residual human DNA found in some vaccines and other products.
Scientists have now hypothesized some cancers and other childhood neurological disorders such as Autism Spectrum Disorder (ASD) may be caused by mutations in the child’s DNA. This conclusion is based upon finding numerous mutations in the brains and/or blood of such children which cannot be found in their parents. Some mutations occur at or soon after conception and are called de novo. Others are acquired mutations that occur after birth due to environmental factors or exposures and are called somatic mutations. One such event could be exposure to residual human DNA from childhood vaccines. SCPI researchers have extensively reviewed the potential health risks posed by this residual human DNA.
Based upon those findings, SCPI does ongoing research and seeks to raise awareness of the potential health risks of manufacturing medical products on human cell lines.